Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130

Journal of Immunology

Volumn 163, Issue 12, 1999, Pages 6651-6658

  Hermanns, Heike M ^c   Radtke, Simone ^c   Haan, Claude ^c   Schmitz Van De Leur, Hildegard ^c   Tavernier, Jan ^a   Heinrich, Peter C ^c   Behrmann, Iris ^b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; GLYCOPROTEIN GP 130; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; ONCOSTATIN M; RECEPTOR; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DIMERIZATION; GENE ACTIVATION; GENE INDUCTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN POLYMERIZATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; CARCINOMA, HEPATOCELLULAR; COS CELLS; CYTOKINE RECEPTOR GP130; CYTOPLASM; DIMERIZATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-6; JANUS KINASE 1; JANUS KINASE 2; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; LYMPHOKINES; MACROMOLECULAR SUBSTANCES; MEMBRANE GLYCOPROTEINS; ONCOSTATIN M; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTORS, CYTOKINE; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-5; RECEPTORS, ONCOSTATIN M; RECEPTORS, OSM-LIF; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0032715992     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Heinrich, P. C., I. Behrmann, G. Müller-Newen, F. Schaper, and L. Graeve. 1998. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334:297.
2. Hirano, T. 1998. Interleukin 6 and its receptor: ten years later. Int. Rev. Immunol. 16:249.
3. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415.
4. Andus, T., T. Geiger, T. Hirano, H. Northoff, U. Ganter, J. Bauer, T. Kishimoto, and P. C. Heinrich. 1987. Recombinant human B cell stimulatory factor 2 (BSF-2/IFN-β2) regulates β-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett. 221:18.
5. Gauldie, J., C. Richards, D. Harnish, P. Lansdorp, and H. Baumann. 1987. Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA 84:7251.
6. Baumann, H., and G. G. Wong. 1989. Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor. J. Immunol. 143:1163.
7. Richards, C. D., T. J. Brown, M. Shoyab, H. Baumann, and J. Gauldie. 1992. Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro. J. Immunol. 148:1731.
8. Shabo, Y., J. Lotem, and L. Sachs. 1989. Autoregulation of interleukin 6 and granulocyte-macrophage colony-stimulating factor in the differentiation of myeloid leukemic cells. Mol. Cell. Biol. 9:4109.
9. Tomida, M., Y. Yamamoto-Yamaguchi, and M. Hozumi, 1984. Purification of a factor inducing differentiation of mouse myeloid leukemic MI cells from conditioned medium of mouse fibroblast L929 cells. J. Biol. Chem. 259:10978.
10. Rose, T. M., and A. G. Bruce. 1991. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. Proc. Natl. Acad. Sci. USA 88:8641.
11. Mosley, B., C. De Imus, D. Friend, N. Boiani, B. Thoma, L. S. Park, and D. Cosman. 1996. Dual oncostatin M (OSM) receptors: cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J. Biol. Chem. 271:32635.
12. Ichihara, M., T. Hara, H. Kim, T. Murate, and A. Miyajima. 1997. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice. Blood 90:165.
13. Stewart, C. L., P. Kaspar, L. J. Brunet, H. Bhatt, I. Gadi, F. Kontgen, and S. J. Abbondanzo. 1992. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 359:76.
14. Chesnokova, V., C. J. Auernhammer, and S. Melmed. 1998. Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response. Endocrinology 139:2209.
15. Miles, S. A., O. Martinez-Maza, A. Rezai, L. Magpantay, T. Kishimoto, S. Nakamura, S. F. Radka, and P. S. Linsley. 1992. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science 255:1432.
16. Nair, B. C., A. L. DeVico, S. Nakamura, T. D. Copeland, Y. Chen, A. Patel, T. O'Neil, S. Oroszlan, R. C. Gallo, and M. G. Sarngadharan. 1992. Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science 255:1430.
17. Tanigawa, T., N. Nicola, G. A. McArthur, A. Strasser, and C. G. Begley. 1995. Differential regulation of macrophage differentiation in response to leukemia inhibitory factor/oncostatin-M/interleukin-6: the effect of enforced expression of the SCL transcription factor. Blood 85:379.
18. Baumann, H., S. Marinkovic-Pajovic, K. A. Won, V. E. Jones, S. P. Campos, G. P. Jahreis, and K. K. Morella. 1992. The action of interleukin 6 and leukaemia inhibitory factor on liver cells. Ciba Found. Symp. 167:100.
19. Kuropatwinski, K. K., C. De Imus, D. Gearing, H. Baumann, and B. Mosley. 1997. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6. J. Biol. Chem. 272:15135.
20. Baumann, H., A. Symes, M. Comeau, K. Morella, Y. Wang, D. Friend, S. Ziegler, J. Fink, and D. Gearing. 1994. Multiple regions within the cytoplasmic domains of the leukemia inhibitory factor receptor and gp130 cooperate in signal transduction in hepatic and neuronal cells. Mol. Cell. Biol. 14:138.
21. Stahl, N., T. J. Farruggella, T. G. Boulton, Z. Zhong, J. E. Darnell, Jr., and G. D. Yancopoulos. 1995. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267:1349.
22. Schiemann, W. P., J. L. Bartoe, and N. M. Nathanson. 1997. Box 3-independent signaling mechanisms are involved in leukemia inhibitory factor receptor α-and gp130-mediated stimulation of mitogen-activated protein kinase: evidence for participation of multiple signaling pathways which converge at Ras. J. Biol. Chem. 272:16631.
23. Tomida, M., T. Heike, and T. Yokota. 1999. Cytoplasmic domains of the leukemia inhibitory factor receptor required for STAT3 activation, differentiation, and growth arrest of myeloid leukemic cells. Blood 93:1934.
24. Starr, R., U. Novak, T. Willson, M. Inglese, V. Murphy, W. Alexander, D. Metcalf, N. Nicola, D. Hilton, and M. Ernst. 1997. Distinct roles for leukemia inhibitory factor receptor α-chain and gp130 in cell type-specific signal transduction. J. Biol. Chem. 272:19982.
25. Nakamura, T., T. Arai, M. Takagi, T. Sawada, T. Matsuda, T. Yokota, and T. Heike, 1998. A selective switch-on system for self-renewal of embryonic stem cells using chimeric cytokine receptors. Biochem. Biophys. Res. Commun. 248:22.
26. Behrmann, I., C. Janzen, C. Gerhartz, H. Schmitz-Van de Leur, H. Hermanns, B. Heesel, L. Graeve, F. Horn, J. Tavernier, and P. C. Heinrich. 1997. A single STAT recruitment module in a chimeric cytokine receptor complex is sufficient for STAT activation. J. Biol. Chem. 272:5269.
27. Tavernier, J., R. Devos, J. Van der Heyden, G. Hauquier, R. Bauden, I. Fache, E. Kawashima, J. Vandekerckhove, R. Contreras, and W. Fiers. 1989. Expression of human and murine interleukin-5 in eukaryotic systems. DNA 8:491.
28. Thiel, S., I. Behrmann, E. Dittrich, L. Muys, J. Tavernier, J. Wijdenes, P. C. Heinrich, and L. Graeve. 1998. Internalization of the interleukin 6 signal transducer gp130 does not require activation of the Jak/STAT pathway. Biochem. J. 330:47.
29. Thiel, S., I. Behrmann, A. Timmermann, H. Dahmen, G. Müller-Newen, F. Schaper, J. Tavernier, V. Pitard, P. C. Heinrich, and L. Graeve. 1999. Identification of a Leu-Ile internalization motif within the cytoplasmic domain of the leukaemia inhibitory factor receptor. Biochem. J. 339:15.
30. Gerhartz, C., B. Heesel, J. Sasse, U. Hemmann, C. Landgraf, J. Schneider-Mergener, F. Horn, P. C. Heinrich, and L. Graeve. 1996. Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT1 activation. J. Biol. Chem. 271:12991.
31. Nakajima, K., Y. Yamanaka, K. Nakae, H. Kojima, M. Ichiba, N. Kiuchi, T. Kitaoka, T. Fukada, M. Hibi, and T. Hirano. 1996. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in MI leukemia cells. EMBO J. 15:3651.
32. Schaper, F., C. Gendo, M. Eck, J. Schmitz, C. Grimm, D. Anhuf, I. M. Kerr, and P. C. Heinrich. 1998. Activation of the tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak 1 and limits acute-phase protein expression. Biochem. J. 335:557.
33. Wegenka, U. M., J. Buschmann, C. Lüttieken, P. C. Heinrich, and F. Horn. 1993. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol. Cell. Biol. 13:276.
34. Baumann, H., K. A. Won, and G. P. Jahreis. 1989. Human hepatocyte-stimulating factor-III and interleukin-6 are structurally and immunologically distinct but regulate the production of the same acute phase plasma proteins. J. Biol. Chem. 264:8046.
35. Zon, L. I., J. F. Moreau, J. W. Koo, B. Mathey-Prevot, and A. D. D'Andrea. 1992. The erythropoietin receptor transmembrane region is necessary for activation by the Friend spleen focus-forming virus gp55 glycoprotein. Mol. Cell. Biol. 12: 2949.
36. Murakami, M., M. Narazaki, M. Hibi, H. Yawata, K. Yasukawa, M. Hamaguchi, T. Taga, and T. Kishimoto. 1991. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc. Natl. Acad. Sci. USA 88:11349.
37. Ihle, J. N., B. A. Witthuhn, F. W. Quelle, K. Yamamoto, and O. Silvennoinen. 1995. Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13:369.
38. Stahl, N., T. G. Boulton, T. Farruggella, N. Y. Ip, S. Davis, B. A. Witthuhn, F. W. Quelle, O. Silvennoinen, G. Barbieri, et al. 1994. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6β receptor components. Science 263:92.
39. Lütticken, C., U. M. Wegenka, J. Yuan, J. Buschmann, C. Schindler, A. Ziemiecki, A. G. Harpur, A. F. Wilks, K. Yasukawa, T. Taga, et al. 1994. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 263:89.
40. Kishimoto, T., S. Akira, M. Narazaki, and T. Taga. 1995. Interleukin-6 family of cytokines and gp130. Blood 86:1243.
41. Tanner, J. W., W. Chen, R. L. Young, G. D. Longmore, and A. S. Shaw. 1995. The conserved box 1 motif of cytokine receptors is required for association with JAK kinases. J. Biol. Chem. 270:6523.
42. Zhang, Y., T. Willson, D. Metcalf, D. Cary, D. J. Hilton, R. Clark, and N. A Nicola. 1998. The box-1 region of the leukemia inhibitory factor receptor α-chain cytoplasmic domain is sufficient for hemopoietic cell proliferation and differentiation. J. Biol. Chem. 273:34370.
43. Ernst, M., U. Novak, S. E. Nicholson, J. E. Layton, and A. R. Dunn. 1999. The carboxyl-terminal domains of gp130-related cytokine receptors are necessary for suppressing embryonic stem cell differentiation: involvement of STAT3. J. Biol. Chem. 274:9729.
44. Wu, Y. Y., and R. A. Bradshaw. 1996. Induction of neurite outgrowth by interleukin-6 is accompanied by activation of Stat3 signaling pathway in a variant PC12 cell (E2) line. J. Biol. Chem. 271:13023.
45. Auguste, P., C. Guillet, M. Fourcin, C. Olivier, J. Veziers, A. Pouplard-Barthelaix, and H. Gascan. 1997. Signaling of type II oncostatin M receptor. J. Biol. Chem. 272:15760.
46. Chen, L., Y. Mory, A. Zilberstein, and M. Revel. 1988. Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-β2. Proc. Natl. Acad. Sci. USA 85:8037.
47. Estrov, Z., B. Samal, R. Lapushin, P. Kellokumpu-Lehtinen, A. A. Sahin, R. Kurzrock, M. Talpaz, and B. B. Aggarwal. 1995. Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation. J. Interferon Cytokine Res. 15:905.
48. Liu, J., M. J. Spence, P. M. Wallace, K. Forcier, I. Hellstrom, and R. E. Vestal. 1997. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene. Cell Growth Differ. 8:667.